These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity. Kirrane TM; Boyer SJ; Burke J; Guo X; Snow RJ; Soleymanzadeh L; Swinamer A; Zhang Y; Madwed JB; Kashem M; Kugler S; O'Neill MM Bioorg Med Chem Lett; 2012 Jan; 22(1):738-42. PubMed ID: 22056746 [TBL] [Abstract][Full Text] [Related]
8. Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors. Kopecky DJ; Hao X; Chen Y; Fu J; Jiao X; Jaen JC; Cardozo MG; Liu J; Wang Z; Walker NP; Wesche H; Li S; Farrelly E; Xiao SH; Kayser F Bioorg Med Chem Lett; 2008 Dec; 18(24):6352-6. PubMed ID: 18993068 [TBL] [Abstract][Full Text] [Related]
10. Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK). MacKinnon CH; Lau K; Burch JD; Chen Y; Dines J; Ding X; Eigenbrot C; Heifetz A; Jaochico A; Johnson A; Kraemer J; Kruger S; Krülle TM; Liimatta M; Ly J; Maghames R; Montalbetti CA; Ortwine DF; Pérez-Fuertes Y; Shia S; Stein DB; Trani G; Vaidya DG; Wang X; Bromidge SM; Wu LC; Pei Z Bioorg Med Chem Lett; 2013 Dec; 23(23):6331-5. PubMed ID: 24138940 [TBL] [Abstract][Full Text] [Related]
11. Discovery of pyrimidine benzimidazoles as Lck inhibitors: part I. Zhang G; Ren P; Gray NS; Sim T; Liu Y; Wang X; Che J; Tian SS; Sandberg ML; Spalding TA; Romeo R; Iskandar M; Chow D; Martin Seidel H; Karanewsky DS; He Y Bioorg Med Chem Lett; 2008 Oct; 18(20):5618-21. PubMed ID: 18793846 [TBL] [Abstract][Full Text] [Related]
12. The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors. Xiang Y; Hirth B; Asmussen G; Biemann HP; Bishop KA; Good A; Fitzgerald M; Gladysheva T; Jain A; Jancsics K; Liu J; Metz M; Papoulis A; Skerlj R; Stepp JD; Wei RR Bioorg Med Chem Lett; 2011 May; 21(10):3050-6. PubMed ID: 21507633 [TBL] [Abstract][Full Text] [Related]
13. 2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocket. Lo HY; Bentzien J; Fleck RW; Pullen SS; Khine HH; Woska JR; Kugler SZ; Kashem MA; Takahashi H Bioorg Med Chem Lett; 2008 Dec; 18(23):6218-21. PubMed ID: 18930400 [TBL] [Abstract][Full Text] [Related]
14. Benzimidazole- and benzoxazole-based inhibitors of Rho kinase. Sessions EH; Yin Y; Bannister TD; Weiser A; Griffin E; Pocas J; Cameron MD; Ruiz C; Lin L; Schürer SC; Schröter T; LoGrasso P; Feng Y Bioorg Med Chem Lett; 2008 Dec; 18(24):6390-3. PubMed ID: 18996009 [TBL] [Abstract][Full Text] [Related]
15. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484 [TBL] [Abstract][Full Text] [Related]
16. 4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors. Shafer CM; Lindvall M; Bellamacina C; Gesner TG; Yabannavar A; Jia W; Lin S; Walter A Bioorg Med Chem Lett; 2008 Aug; 18(16):4482-5. PubMed ID: 18672368 [TBL] [Abstract][Full Text] [Related]
17. Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors. Das J; Liu C; Moquin RV; Lin J; Furch JA; Spergel SH; Doweyko AM; McIntyre KW; Shuster DJ; O'Day KD; Penhallow B; Hung CY; Kanner SB; Lin TA; Dodd JH; Barrish JC; Wityak J Bioorg Med Chem Lett; 2006 May; 16(9):2411-5. PubMed ID: 16481166 [TBL] [Abstract][Full Text] [Related]